NIH-funded research R01 grant

Developing a catheter that prevents bloodstream infections using electrochemical reactions

Official title: Electrochemical Catheter for Prevention of Central Line-Associated Bloodstream Infection

Funded at Mayo Clinic Rochester · NIH-11012374 · Data updated 2026-11-12

This study is testing a new kind of central venous catheter that makes a special solution to help prevent infections in people who need these catheters, aiming to keep you safer without using antibiotics.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startFebruary 20, 2023
Project endJanuary 31, 2027
Funding year2025
Award (this year)$382,186
NIH project number5R01HL166238-03
Project IDNIH-11012374 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients who require central venous catheters for treatments such as hemodialysis or those in critical care settings.

Less likely to help

Patients who do not require central venous catheters or those with existing severe infections may not benefit from this research.

What this research studies

This research focuses on creating a new type of central venous catheter that uses electrochemical reactions to generate a biocide called hypochlorous acid (HOCl) within the catheter lumen. By doing so, it aims to prevent central line-associated bloodstream infections (CLABSI), which can occur when pathogens enter the bloodstream through these catheters. The approach is non-antibiotic, which may help combat antibiotic resistance. The researchers have already shown promising results in preliminary tests, indicating that this method could effectively reduce infection rates.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of bloodstream infections in patients with central venous catheters.

How similar studies have gone: Other research has shown success with similar electrochemical approaches in preventing infections, indicating potential for this novel method.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Patel, Robin — Mayo Clinic Rochester
  • Study coordinator: Patel, Robin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.